HETEROCYCLIC COMPOUND AS A PROTEIN KINASE INHIBITOR

The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof.The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein k...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Dongkyu, LEE, Hyuk Woo, JUNG, Soo Yeon, KIM, Seung Chan, KI, So Young, YU, Ha Na, JI, Mi Kyung, PARK, Ji-Yeon, LEE, Ye-Lim, LEE, Ho-Youl, KIM, Myeongjoong
Format Patent
LanguageEnglish
French
German
Published 14.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof.The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
Bibliography:Application Number: EP20180869085